TMD & Associates’s Amgen AMGN Stock Holding History

TMD & Associates’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-2,386	Closed	-$387K	–	30
2015 Q4	$387K	Buy	+2,386	New	+$375K	0.35%	40

Other funds holding AMGN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

TMD & Associates's AMGN Position: Q1 2016 in Review

TMD & Associates sold out of Amgen (AMGN) in Q1 2016, closing a stake of 2,386 shares — an estimated $387K sold.

TMD & Associates first reported a position in AMGN in Q4 2015 and held it in 1 quarter. The position peaked at $387K in Q4 2015. 1,434 funds tracked by Wall St. Rank hold AMGN as of Q1 2016.

TMD & Associates reported no remaining Amgen position as of Q1 2016 after selling out during the quarter.
TMD & Associates sold 2,386 Amgen shares in Q1 2016, an estimated $387K.
TMD & Associates first reported a position in Amgen in Q4 2015 and held it in 1 quarter.
TMD & Associates's Amgen position peaked at $387K in Q4 2015.
1,434 funds tracked by Wall St. Rank held Amgen as of Q1 2016.

Based on TMD & Associates's 13F filing for Q1 2016, filed 16 May 2016.